Advanced kidney cancer patients now able to access Votrient®▼ (pazopanib)
7 March 2011 | By GlaxoSmithKline
Patients living in Scotland with renal cell carcinoma, will have access to a new treatment choice, as Votrient® (pazopanib)...
List view / Grid view
News
Quotient Clinical announces major expansion of its GMP manufacturing and formulation development capacity
3 March 2011 | By The Scott Partnership
To accommodate demand for its RapidFACT Service...
Webinar: how the human tumour micro-environment impacts tumour cell biology and drug pharmacology
3 March 2011 | By The Scott Partnership
PRECOS will be discussing in vitro and in vivo modeling of the human TME...
The MET ONE 3445 Particle Counter will save you time!
2 March 2011 | By HACH LANGE
Did you know that there is a new 100LPM MET ONE Particle Counter available from HACH LANGE?...
GSK outlines new plan to drive recruitment & attract graduate talent in the UK
2 March 2011 | By GlaxoSmithKline
New plans to encourage students graduating from UK to consider a career with GSK...
European Commission continues to support Avastin
2 March 2011 | By Roche
Avastin in combination with paclitaxel will remain a treatment option for women with metastatic breast cancer in Europe...
Pfizer completes acquisition of King Pharmaceuticals, Inc.
1 March 2011 | By Pfizer
Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp...
Genzyme completes sale of pharmaceuticals business to International Chemical Investors Group
1 March 2011 | By Genzyme Corporation
Genzyme completed the sale of its pharmaceutical intermediates business...
UCB establishes innovative collaboration with Harvard University
28 February 2011 | By UCB
UCB announced today that it has concluded an innovative research collaboration agreement with Harvard University...
David Redfern appointed as new Chairman of ViiV Healthcare
25 February 2011 | By GlaxoSmithKline
GSK, ViiV Healthcare, & Pfizer announced the appointment of David Redfern as the new Chairman of the Board for ViiV Healthcare...
Sigma® Life Science launches pre-designed CompoZr® Knockout ZFN for entire human genome
24 February 2011 | By kdm communications limited
The new offer, attractively priced to fit within the budget of a typical laboratory...
Nampak Healthcare proposes major investment in Portsmouth
24 February 2011 | By Crosland Communications Ltd
Nampak Healthcare announced plans to invest in a new facility in Segensworth...
GE Healthcare appoints Kieran Murphy as Life Sciences CEO, successor to Peter Ehrenheim
24 February 2011 | By GE Healthcare
Kieran Murphy will be promoted to succeed current Life Sciences President and CEO...
Court of Appeals overturns $1.8bn patent verdict for Centocor Ortho Biotech Inc.
23 February 2011 | By Johnson & Johnson
Centocor received a decision from the Court of Appeals overturning a 2009 federal court jury verdict that awarded the company $1.8 billion...
Brecon appoints Director of QA and Regulatory Affairs
23 February 2011 | By AD Communications
Brecon Pharmaceuticals, has appointed Qualified Person Kay O'Hagan as director of quality assurance & regulatory affairs...
